Shimai Pharmaceutical

BRIEF: Shimai Pharma gets CSRC nod for Hong Kong IPO

Zhejiang Shimai Pharmaceutical Co. Ltd., a developer of T-cell engager (TCE) therapies, has been cleared by the China Securities Regulatory Commission (CSRC) for its overseas listing, marking an important step…

Recent Articles

RELATED ARTICLES

  1. BRIEF: InSilico gets CSRC nod for Hong Kong IPO
  2. BRIEF: Biren Technology gets CSRC nod for Hong Kong IPO
  3. BRIEF:  Busy Ming Hong Kong IPO gets CSRC nod
  4. BRIEF: Kuxin Microelectronics gets CSRC nod for Hong Kong IPO
  5. BRIEF: Delton Technology gets CSRC nod for Hong Kong listing
    001389.SHE
  6. BRIEF: Capital Securities gets regulatory nod, refiles for Hong Kong IPO
    601136.SHG
  7. Eye drug maker VivaVision feels the strain in IPO funding dash
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva